Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USPL1 USP17L22 USP17L8 USP17L13	1.42e-14	137	158	16	GO:0019783
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.61e-14	114	158	15	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	5.78e-14	124	158	15	GO:0101005
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USPL1 USP17L22 USP17L8 USP17L13	2.84e-12	192	158	16	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	HGF USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 ADAM30 USP17L10 USP17L19 USP17L18 BMP1 JMJD7 USP17L17 GZMB USP17L6P USPL1 USP17L22 KLK13 USP17L8 TMPRSS11A USP17L13	2.03e-09	654	158	23	GO:0008233
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXNA3 PLXNA4 PLXNA1	1.01e-04	12	158	3	GO:0017154
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USPL1 USP17L22 USP17L8 USP17L13	1.93e-14	144	158	16	GO:0070646
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	4.10e-14	125	158	15	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 HIF1A USP17L2 USP17L12 ATG7 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 IVNS1ABP UBE2O UBE2D1 NEUROD2 UBE2D4 USP17L17 CHFR USP17L6P USPL1 USP17L22 CRBN USP17L8 USP17L13	2.04e-07	1009	158	25	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L21 HIF1A USP17L2 USP17L12 ATG7 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 IVNS1ABP UBE2O UBE2D1 NEUROD2 UBE2D4 USP17L17 CHFR USP17L6P USPL1 USP17L22 CRBN USP17L8 USP17L13	6.50e-07	1074	158	25	GO:0043687
GeneOntologyBiologicalProcess	olfactory nerve formation	PLXNA3 PLXNA1	5.83e-05	2	158	2	GO:0021628
GeneOntologyCellularComponent	endoplasmic reticulum membrane	TMEM67 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 CERT1 USP17L18 SORT1 KCNA2 SEC24C USP17L17 VPS13A USP17L6P PDIA5 SCFD1 PLD1 USP17L22 NOTCH2 USP17L8 USP17L13 SLC35B1	1.22e-05	1293	157	25	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	TMEM67 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 CERT1 USP17L18 SORT1 KCNA2 SEC24C USP17L17 VPS13A USP17L6P PDIA5 SCFD1 PLD1 USP17L22 NOTCH2 USP17L8 USP17L13 SLC35B1	1.32e-05	1299	157	25	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	TMEM67 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 CERT1 USP17L18 SORT1 KCNA2 SEC24C USP17L17 VPS13A USP17L6P PDIA5 SCFD1 PLD1 USP17L22 NOTCH2 USP17L8 USP17L13 SLC35B1	1.89e-05	1327	157	25	GO:0042175
GeneOntologyCellularComponent	semaphorin receptor complex	PLXNA3 PLXNA4 PLXNA1	1.12e-04	13	157	3	GO:0002116
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.33e-22	16	156	12	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.33e-22	16	156	12	IPR006861
Domain	USP_1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USPL1 USP17L22 USP17L8 USP17L13	1.65e-17	70	156	15	PS00972
Domain	USP_2	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USPL1 USP17L22 USP17L8 USP17L13	2.07e-17	71	156	15	PS00973
Domain	USP_3	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USPL1 USP17L22 USP17L8 USP17L13	2.60e-17	72	156	15	PS50235
Domain	USP_dom	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USPL1 USP17L22 USP17L8 USP17L13	2.60e-17	72	156	15	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USPL1 USP17L22 USP17L8 USP17L13	2.60e-17	72	156	15	IPR001394
Domain	USP_CS	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	2.37e-16	66	156	14	IPR018200
Domain	UCH	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	7.11e-16	71	156	14	PF00443
Domain	EGF_3	TNC ADAM30 BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	4.65e-06	235	156	11	PS50026
Domain	EGF-like_dom	TNC ADAM30 BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	8.06e-06	249	156	11	IPR000742
Domain	EGF_1	TNC ADAM30 BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	1.01e-05	255	156	11	PS00022
Domain	EGF-like_CS	TNC ADAM30 BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	1.25e-05	261	156	11	IPR013032
Domain	EGF_2	TNC ADAM30 BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	1.45e-05	265	156	11	PS01186
Domain	EGF	TNC BMP1 FBLN1 FAT2 HEG1 EFEMP1 TENM4 MUC17 EGFL8 NOTCH2	2.90e-05	235	156	10	SM00181
Domain	Plexin_cytopl	PLXNA3 PLXNA4 PLXNA1	4.63e-05	9	156	3	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA4 PLXNA1	4.63e-05	9	156	3	IPR013548
Domain	Plexin	PLXNA3 PLXNA4 PLXNA1	4.63e-05	9	156	3	IPR031148
Domain	IPT	PLXNA3 NFKB1 PLXNA4 PLXNA1	7.08e-05	27	156	4	SM00429
Domain	EGF_CA	BMP1 FBLN1 FAT2 HEG1 EFEMP1 EGFL8 NOTCH2	7.44e-05	122	156	7	SM00179
Domain	EGF-like_Ca-bd_dom	BMP1 FBLN1 FAT2 HEG1 EFEMP1 EGFL8 NOTCH2	8.24e-05	124	156	7	IPR001881
Domain	EGF_CA	BMP1 FBLN1 HEG1 EFEMP1 EGFL8 NOTCH2	8.36e-05	86	156	6	PF07645
Domain	TIG	PLXNA3 NFKB1 PLXNA4 PLXNA1	1.24e-04	31	156	4	PF01833
Domain	IPT	PLXNA3 NFKB1 PLXNA4 PLXNA1	1.40e-04	32	156	4	IPR002909
Domain	EGF_Ca-bd_CS	BMP1 FBLN1 HEG1 EFEMP1 EGFL8 NOTCH2	1.63e-04	97	156	6	IPR018097
Domain	EGF_CA	BMP1 FBLN1 HEG1 EFEMP1 EGFL8 NOTCH2	1.82e-04	99	156	6	PS01187
Domain	ASX_HYDROXYL	BMP1 FBLN1 HEG1 EFEMP1 EGFL8 NOTCH2	1.93e-04	100	156	6	PS00010
Domain	Ig_E-set	PLXNA3 NPC2 NFKB1 PLXNA4 ASCC3 PLXNA1	2.39e-04	104	156	6	IPR014756
Domain	EGF-type_Asp/Asn_hydroxyl_site	BMP1 FBLN1 HEG1 EFEMP1 EGFL8 NOTCH2	2.64e-04	106	156	6	IPR000152
Domain	Growth_fac_rcpt_	TMEM67 TNC BMP1 FBLN1 EFEMP1 CCN1 NOTCH2	3.41e-04	156	156	7	IPR009030
Domain	SHR-BD	VPS13A VPS13B	4.11e-04	4	156	2	IPR009543
Domain	VPS13_C	VPS13A VPS13B	4.11e-04	4	156	2	PF16909
Domain	VPS13_C	VPS13A VPS13B	4.11e-04	4	156	2	IPR031645
Domain	SHR-BD	VPS13A VPS13B	4.11e-04	4	156	2	PF06650
Domain	-	PLXNA3 DMXL2 STXBP5 SORT1 NWD2 CFAP52 NBEAL2 PLXNA4 EIF2A PLXNA1	5.00e-04	333	156	10	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	PLXNA3 DMXL2 STXBP5 SORT1 NWD2 CFAP52 NBEAL2 PLXNA4 EIF2A PLXNA1	5.24e-04	335	156	10	IPR015943
Domain	EGF	TNC BMP1 FAT2 HEG1 EGFL8 NOTCH2	6.66e-04	126	156	6	PF00008
Domain	Autophagy-rel_C	VPS13A VPS13B	6.82e-04	5	156	2	IPR015412
Domain	ATG_C	VPS13A VPS13B	6.82e-04	5	156	2	PF09333
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	4.45e-19	45	117	14	MM15671
Pathway	REACTOME_DEUBIQUITINATION	UIMC1 USP17L21 HIF1A USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 UBE2D1 USP17L17 USP17L6P KDM1B USP17L22 USP17L8 USP17L13	5.02e-12	262	117	18	MM15286
Pathway	REACTOME_DEUBIQUITINATION	UIMC1 USP17L21 HIF1A USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 UBE2D1 USP17L17 KDM1B USP17L22 USP17L8 USP17L13	4.54e-11	299	117	18	M27574
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 HIF1A USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	5.17e-11	191	117	15	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	RAF1 HGF USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 DUSP5 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P DLG2 USP17L22 USP17L8 USP17L13	1.25e-10	318	117	18	MM15278
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 HIF1A USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	4.06e-10	221	117	15	M27578
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	PLXNA3 DPYSL2 PLXNA4 PLXNA1	5.73e-06	15	117	4	MM15031
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	PLXNA3 DPYSL2 PLXNA4 PLXNA1	7.59e-06	16	117	4	M8245
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA3 PLXNA4 PLXNA1	4.51e-05	9	117	3	MM15030
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	UIMC1 USP17L21 HIF1A USP17L2 USP17L12 TNC USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 UBE2D1 SEC24C JMJD7 CCN1 USP17L17 MUC17 USP17L6P SCFD1 KDM1B USP17L22 HSPA8 USP17L8 USP17L13	1.52e-04	1389	117	25	MM15307
Pathway	WP_10Q22Q23_COPY_NUMBER_VARIATION	LRIT2 NFKB1 BUB1B CCSER2 TSPAN14	1.86e-04	64	117	5	M48102
Pathway	WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS	HIF1A NFKB1 PLD1	1.90e-04	14	117	3	M45553
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PLXNA4 PLXNA1	1.90e-04	14	117	3	MM15029
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA3 PLXNA4 PLXNA1	1.90e-04	14	117	3	M7578
Pathway	WP_ONCOSTATIN_M_SIGNALING	RAF1 HIF1A CCN1 NFKB1 OSMR	2.01e-04	65	117	5	M39562
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PLXNA4 PLXNA1	2.88e-04	16	117	3	M16498
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	UIMC1 USP17L21 HIF1A USP17L2 USP17L12 TNC USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 UBE2D1 SEC24C JMJD7 CCN1 USP17L17 MUC17 SCFD1 KDM1B USP17L22 HSPA8 USP17L8 USP17L13	3.85e-04	1475	117	25	M19806
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.32e-28	21	161	14	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	3.60e-28	22	161	14	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	2.19e-27	24	161	14	8995226
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	4.75e-27	33	161	15	20228807
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	4.96e-27	25	161	14	21115691
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	15780755
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	17109758
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	9806828
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	20403174
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	11941478
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	20388806
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.47e-27	34	161	15	21448158
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.07e-26	26	161	14	35816173
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.48e-26	35	161	15	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.48e-26	35	161	15	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	2.52e-26	36	161	15	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	4.22e-26	37	161	15	20228808
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	8.50e-26	29	161	14	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	9.46e-22	50	161	14	31806660
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 FAT2 HOXC8 TENM4 UBE2D4 USP17L17 PLXNA4 USP17L6P USP17L22 USP17L8 USP17L13	4.01e-10	674	161	19	37196079
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA3 PLXNA4 PLXNA1	3.88e-07	4	161	3	25518740
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA3 PLXNA4 PLXNA1	3.88e-07	4	161	3	11306810
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	1.45e-06	119	161	7	28625976
Pubmed	Phospholipase D1 has a pivotal role in interleukin-1β-driven chronic autoimmune arthritis through regulation of NF-κB, hypoxia-inducible factor 1α, and FoxO3a.	HIF1A NFKB1 PLD1	1.93e-06	6	161	3	23689131
Pubmed	The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator.	RAF1 UBE2D1 HSPA8	1.93e-06	6	161	3	15215316
Pubmed	Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice.	PLXNA3 PLXNA4 PLXNA1	3.36e-06	7	161	3	19655386
Pubmed	Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points.	PLXNA3 PLXNA4 PLXNA1	3.36e-06	7	161	3	19063725
Pubmed	Integration of opposing semaphorin guidance cues in cortical axons.	PLXNA3 PLXNA4 PLXNA1	5.36e-06	8	161	3	22368082
Pubmed	The expression of plexins during mouse embryogenesis.	PLXNA3 PLXNA4 PLXNA1	5.36e-06	8	161	3	15661641
Pubmed	The role of neuropilins in cell signalling.	PLXNA3 PLXNA4 PLXNA1	8.01e-06	9	161	3	19909241
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DPYSL2 RARS1 USP17L12 KIF26B MYO19 NCBP1 IVNS1ABP IGSF10 UBE2D1 NEUROD2 ZNF592 VPS13A PLXNA4 HSPA8	9.22e-06	736	161	14	29676528
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	DPYSL2 RARS1 MAT2A USP17L5 UBE2D1 UBE2D4 IGHG1 EIF4A1 CPNE3 DHX32 CTNNA1 SCFD1 ZFP69B CPNE4 HSPA8	9.78e-06	844	161	15	25963833
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	RAF1 HGF HIF1A MAP3K4 FZD5 NFKB1 BUB1B CTNNA1 OSMR CDC6	9.85e-06	371	161	10	25241761
Pubmed	Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development.	PLXNA3 PLXNA4 PLXNA1	1.14e-05	10	161	3	18804103
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L2 USP17L6P USP17L8	1.14e-05	10	161	3	24207026
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PLXNA3 TMEM67 DPYSL2 NPC2 SORT1 IGSF10 BMP1 FBLN1 HEG1 EFEMP1 SEC24C CCN1 TXNDC16 PDIA5 CTNNA1 OSMR PLXNA1 NOTCH2	1.26e-05	1201	161	18	35696571
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DMXL2 CDC42BPA CENPC TFCP2 UBE2O KIDINS220 SEC24C SACS BUB1B CCSER2 VPS13A PDIA5 CTNNA1 SCFD1 CRYBG3 ASCC3 EIF2A HSPA8 VPS13B NOTCH2	1.93e-05	1487	161	20	33957083
Pubmed	Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin.	TNC NFKB1 CTNNA1 PLXNA1	2.07e-05	35	161	4	16452166
Pubmed	Deletion of Sema3a or plexinA1/plexinA3 causes defects in sensory afferent projections of statoacoustic ganglion neurons.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	23991118
Pubmed	Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	25839327
Pubmed	On and off retinal circuit assembly by divergent molecular mechanisms.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	24179230
Pubmed	PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	31690636
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L2 USP17L6P USP17L8	2.08e-05	12	161	3	24695638
Pubmed	Transcriptome profiling reveals expression signatures of cranial neural crest cells arising from different axial levels.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	28407732
Pubmed	Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.	PLXNA3 PLXNA4 PLXNA1	2.08e-05	12	161	3	21270798
Pubmed	Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer.	HIF1A MUC17	2.13e-05	2	161	2	22970168
Pubmed	NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma.	HIF1A NFKB1	2.13e-05	2	161	2	20813154
Pubmed	A Rev-CBP80-eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA.	NCBP1 EIF4A1	2.13e-05	2	161	2	30239828
Pubmed	Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.	HGF TNC	2.13e-05	2	161	2	15059978
Pubmed	Infertility in Fabry's Disease: role of hypoxia and inflammation in determining testicular damage.	HIF1A NFKB1	2.13e-05	2	161	2	38455658
Pubmed	Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein.	HIF1A NFKB1	2.13e-05	2	161	2	12488445
Pubmed	HIF-1α restricts NF-κB-dependent gene expression to control innate immunity signals.	HIF1A NFKB1	2.13e-05	2	161	2	25510503
Pubmed	Hypoxia induces genomic DNA demethylation through the activation of HIF-1α and transcriptional upregulation of MAT2A in hepatoma cells.	HIF1A MAT2A	2.13e-05	2	161	2	21460102
Pubmed	Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance?	HIF1A ACTN3	2.13e-05	2	161	2	20005538
Pubmed	Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.	HIF1A NFKB1	2.13e-05	2	161	2	24535079
Pubmed	2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.	HIF1A NFKB1	2.13e-05	2	161	2	28000883
Pubmed	Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1.	HGF HIF1A	2.13e-05	2	161	2	18979225
Pubmed	Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions.	HIF1A NFKB1	2.13e-05	2	161	2	21887310
Pubmed	Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.	HGF HIF1A	2.13e-05	2	161	2	15240510
Pubmed	Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells.	HIF1A NFKB1	2.13e-05	2	161	2	12821113
Pubmed	NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.	HIF1A NFKB1	2.13e-05	2	161	2	19671685
Pubmed	Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.	HIF1A NFKB1	2.13e-05	2	161	2	25318952
Pubmed	Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.	TIAL1 GZMB	2.13e-05	2	161	2	17869012
Pubmed	Upregulated Fibulin-1 Increased Endometrial Stromal Cell Viability and Migration by Repressing EFEMP1-Dependent Ferroptosis in Endometriosis.	FBLN1 EFEMP1	2.13e-05	2	161	2	35127942
Pubmed	Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis.	FCRL3 NFKB1	2.13e-05	2	161	2	16476711
Pubmed	Activation of the yeast SSK2 MAP kinase kinase kinase by the SSK1 two-component response regulator.	MAP3K4 BUB1B	2.13e-05	2	161	2	9482735
Pubmed	Hypoxia and P. gingivalis synergistically induce HIF-1 and NF-κB activation in PDL cells and periodontal diseases.	HIF1A NFKB1	2.13e-05	2	161	2	25861162
Pubmed	CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway.	DPYSL2 HIF1A	2.13e-05	2	161	2	35927239
Pubmed	Distinct cytoplasmic domains in Plexin-A4 mediate diverse responses to semaphorin 3A in developing mammalian neurons.	PLXNA3 PLXNA4	2.13e-05	2	161	2	24619647
Pubmed	[Effects of intermittent hypoxia stimulation with different frequencies on HT22 cell viability and expression of Hif-1α and p-NF-κB].	HIF1A NFKB1	2.13e-05	2	161	2	33665657
Pubmed	NF-kappaB regulates the transcription of protein tyrosine kinase Tec.	TEC NFKB1	2.13e-05	2	161	2	19843184
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DMXL2 CDC42BPA STXBP5 RGP1 KIDINS220 VPS13A SCFD1 PLD1 PLXNA1 VPS13B NOTCH2	2.51e-05	504	161	11	34432599
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	IRF2BP2 CCN1 ZNF592 BUB1B SPEN HSPA8 NOTCH2	2.54e-05	184	161	7	32908313
Pubmed	Plexin signaling via off-track and rho family GTPases.	PLXNA3 PLXNA4 PLXNA1	2.69e-05	13	161	3	11604131
Pubmed	Functional assembly of accessory optic system circuitry critical for compensatory eye movements.	PLXNA3 PLXNA4 PLXNA1	2.69e-05	13	161	3	25959730
Pubmed	Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.	PLXNA3 PLXNA4 PLXNA1	2.69e-05	13	161	3	22723296
Pubmed	TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination during L. monocytogenes infection.	ATG7 UBE2D1 HSPA8	2.69e-05	13	161	3	36576150
Pubmed	Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.	PLXNA3 PLXNA4 PLXNA1	2.69e-05	13	161	3	10520995
Pubmed	Chromosomal localization of three pulmonary surfactant protein genes in the mouse.	RAF1 BMP1 GZMB	2.69e-05	13	161	3	1346779
Pubmed	A midline switch of receptor processing regulates commissural axon guidance in vertebrates.	PLXNA3 PLXNA4 PLXNA1	3.41e-05	14	161	3	20159958
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L2 USP17L6P USP17L8	3.41e-05	14	161	3	11793228
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DMXL2 DPYSL2 TNC STXBP5 RADIL KCNA2 SACS DLG2 CTNNA1	3.73e-05	347	161	9	17114649
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RAF1 DMXL2 DPYSL2 TNC ACTN3 RBM39 UBE2O NWD2 KIDINS220 TENM4 SEC24C SACS IGHG1 PLXNA4 DLG2 CTNNA1 CPNE4 PIP4K2C HSPA8	3.77e-05	1431	161	19	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PLXNA3 UIMC1 OR1M1 CENPC SANBR NCBP1 ACTN3 CCDC148 SCML4 TIAL1 SACS EIF4A1 VPS13A PLXNA4 DLG2 USPL1 DTHD1 SPEN HSPA8	4.17e-05	1442	161	19	35575683
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DMXL2 DPYSL2 CDC42BPA NCBP1 RBM39 RCOR2 NWD2 KIDINS220 SEC24C SACS EIF4A1 CPNE3 PDIA5 KDM1B SPEN HSPA8	4.59e-05	1082	161	16	38697112
Pubmed	Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1.	PLXNA3 PLXNA4 PLXNA1	5.22e-05	16	161	3	17356169
Pubmed	Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus.	PLXNA3 PLXNA4 PLXNA1	5.22e-05	16	161	3	18489001
Pubmed	Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles.	RAF1 KIDINS220 CPNE3 PIP4K2C HSPA8	6.06e-05	89	161	5	27034005
Pubmed	Semaphorin signaling facilitates cleft formation in the developing salivary gland.	PLXNA3 PLXNA4 PLXNA1	6.31e-05	17	161	3	17626059
Pubmed	Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections.	PLXNA3 PLXNA4 PLXNA1	6.31e-05	17	161	3	11683995
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L13	1.60e-18	79	161	13	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 NELFA USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L13	6.81e-14	222	161	14	chr4p16
Cytoband	10q23.1	LRIT2 CCSER2 TSPAN14	7.12e-05	23	161	3	10q23.1
GeneFamily	Plexins	PLXNA3 PLXNA4 PLXNA1	1.12e-05	9	94	3	683
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	RAF1 MAP3K4 MAP3K19	2.54e-04	24	94	3	654
GeneFamily	Fibulins	FBLN1 EFEMP1	7.34e-04	8	94	2	556
GeneFamily	Copines	CPNE3 CPNE4	9.40e-04	9	94	2	829
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CHFR USP17L6P USP17L22 USP17L8 USP17L13	3.86e-18	86	158	15	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	6.73e-15	112	158	14	MM1095
Coexpression	GERY_CEBP_TARGETS	HGF USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	5.42e-14	160	158	15	MM1155
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DMXL2 HIF1A CDC42BPA CENPC DUSP5 RBM39 MAP3K4 AZIN1 TDRD7 PTPN4 HEG1 KIDINS220 CCN1 SACS NFKB1 BUB1B CCSER2 VPS13A CRYBG3 OSMR ASCC3 SPEN VPS13B ZMYM4	3.75e-10	856	158	24	M4500
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 INPP5B USP17L5 NPC2 USP17L10 USP17L19 USP17L18 BMP1 UBE2O USP17L17 FZD5 NBEAL2 USP17L6P USP17L22 USP17L8 USP17L13	2.42e-09	647	158	20	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	TSNAXIP1 USP17L21 DPYSL2 USP17L2 USP17L12 CENPC USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ITGAL ADH1A USP17L18 UBE2D1 TIAL1 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	2.04e-06	1072	158	21	MM1031
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L2 USP17L12 PDE1B USP17L20 USP17L11 INPP5B USP17L5 NPC2 USP17L10 USP17L19 USP17L18 BMP1 UBE2O USP17L17 FZD5 NBEAL2 USP17L6P USP17L22 ZNF681 USP17L8 USP17L13	4.70e-06	1226	158	22	MM979
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L2 IQCH USP17L12 ATG7 TNC USP17L20 STXBP5 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 GZMB USP17L6P PDIA5 USP17L22 USP17L8 USP17L13 SLC35B1	1.12e-05	1198	158	21	MM1062
Coexpression	GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	NELFA INPP5B ITGAL SORT1 PTOV1 UBE2D1 RESF1 HSPA8	2.82e-05	198	158	8	M5344
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CENPC ITGAL RBM39 PTPN4 FCRL3 RESF1 GZMB CCSER2 DTHD1	3.63e-08	200	155	9	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADH1A SCML4 FBLN1 NLRP10 EFEMP1 CCN1 TXNDC16 ZNF471	2.44e-07	181	155	8	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADH1A SCML4 FBLN1 NLRP10 EFEMP1 CCN1 TXNDC16 ZNF471	2.44e-07	181	155	8	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H ITGAL SCML4 PTPN4 FCRL3 GZMB CCSER2 DTHD1	3.83e-07	192	155	8	e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H SCML4 PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	3.98e-07	193	155	8	46f94a1062b098205e8ce3ed380c0202a4d97678
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H SCML4 PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	4.14e-07	194	155	8	5a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H SCML4 PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	4.14e-07	194	155	8	7d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H SCML4 PTPN4 HEG1 FCRL3 GZMB CCSER2	2.95e-06	177	155	7	0f2616a81f8fbede77c860b2126e3fa826672da3
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 HEG1 FCRL3 GZMB	3.18e-06	179	155	7	de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 HEG1 FCRL3 GZMB	3.18e-06	179	155	7	def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H SCML4 PTPN4 HEG1 FCRL3 GZMB DTHD1	3.95e-06	185	155	7	593eceb3dfcc662c892a840ba29ab687c6886c01
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNC IGSF10 FBLN1 NWD2 TENM4 PLXNA4 NOTCH2	4.87e-06	191	155	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNC KIF26B IGSF10 FBLN1 PLXNA4 DLG2 OSMR	5.40e-06	194	155	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	VE-CD8-CD8_1\|VE / Condition, Cell_class and T cell subcluster	ITGAL PTPN4 FCRL3 RESF1 GZMB CCSER2 DTHD1	6.17e-06	198	155	7	9747a486fddec917a3753651de0b2079ac2385ee
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_CTL\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	APOBEC3H SCML4 PTPN4 GZMB CCSER2 DTHD1 HSPA8	6.37e-06	199	155	7	a9b7465ecd9fd7c5ad35970ff7c3c93b4ec2c4c3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TNC IGSF10 FBLN1 CCN1 NFKB1 PLXNA4 OSMR	6.37e-06	199	155	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HGF TNC KIF26B IGSF10 FBLN1 PLXNA4 OSMR	6.59e-06	200	155	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ITGAL RBM39 PTPN4 RESF1 GZMB CCSER2 DTHD1	6.59e-06	200	155	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	1.74e-05	155	155	6	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	1.74e-05	155	155	6	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KIF26B PTPN4 FCRL3 TENM4 GZMB PLXNA4	1.93e-05	158	155	6	1bf692f1e85f677cd62805437b7a59cfaf3b0449
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HTR3A ARMC12 SCML4 FBLN1 FZD5	2.63e-05	100	155	5	2e1c6fa2b48a6e3367b76b79dec58aea9c4662e0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CENPC MAP3K4 PTPN4 SACS CCSER2 VPS13A	2.64e-05	167	155	6	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	APOBEC3H PTPN4 GZMB CCSER2 VPS13A PLXNA4	3.02e-05	171	155	6	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 FCRL3 GZMB	3.22e-05	173	155	6	fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337
ToppCell	367C-Lymphocytic-ILC-ILC-2\|367C / Donor, Lineage, Cell class and subclass (all cells)	UIMC1 PTPN4 GZMB VPS13A PLD1 ZMYM4	3.22e-05	173	155	6	0451450605521fecb27a958628870d268adfb023
ToppCell	LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 FCRL3 GZMB	3.22e-05	173	155	6	dcde3252ff96448d3a61039a4948c74ad321a218
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	STXBP5 INPP5B DUSP5 C4orf36 GZMB PLXNA4	3.33e-05	174	155	6	69723f5666abc3af5f0431901a60246c9915ef81
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGF INPP5B KCNA2 GZMB CCSER2 TEC	3.44e-05	175	155	6	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HGF TNC NLRP10 CCN1 CDC6 NOTCH2	3.44e-05	175	155	6	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HGF TNC NLRP10 CCN1 CDC6 NOTCH2	3.44e-05	175	155	6	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPYSL2 DUSP5 ADH1A FBLN1 HEG1 NOTCH2	3.44e-05	175	155	6	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGF INPP5B KCNA2 GZMB CCSER2 TEC	3.44e-05	175	155	6	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H SCML4 PTPN4 GZMB BUB1B CCSER2	3.55e-05	176	155	6	6b1cf1e98b4509e87f9eea827fa7090ce1e504f1
ToppCell	facs-Liver-Non-hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPYSL2 APOBEC3H ITGAL RBM39 FBLN1 OSMR	3.66e-05	177	155	6	f73ed860685a724591d0f543a9ac4e868aff92f5
ToppCell	ASK452-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	CDC42BPA INPP5B DUSP5 C4orf36 GZMB PLXNA4	3.90e-05	179	155	6	c3cf49c069e66db16d2fce1de4c52a4c4fe7e832
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	UIMC1 ATG7 TFCP2 VPS13A PLD1 ZMYM4	3.90e-05	179	155	6	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	4.02e-05	180	155	6	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	4.02e-05	180	155	6	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PTPN4 FCRL3 GZMB CCSER2 DTHD1 IL23R	4.02e-05	180	155	6	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 HEG1 CEP72 SCN5A BUB1B PLXNA1	4.15e-05	181	155	6	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 FCRL3 GZMB	4.41e-05	183	155	6	59e8d07556390828f7557ba3fd2f7d49851498b7
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 FCRL3 GZMB	4.41e-05	183	155	6	2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADH1A IGSF10 FBLN1 KCNA2 EFEMP1 CCN1	4.69e-05	185	155	6	355b03c7ea438681e11a2b872c798c9ea26e1486
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	APOBEC3H ITGAL SCML4 FCRL3 GZMB DTHD1	4.97e-05	187	155	6	b5c8322ee728303425be677aa0c36fa552fd0f59
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGAL SCML4 FCRL3 GZMB CCSER2 DTHD1	5.12e-05	188	155	6	6686dbba990066568aa7573e70a7db8b4758f457
ToppCell	LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOBEC3H TEC ITGAL SCML4 GZMB	5.15e-05	115	155	5	3ab39d28717ae585d84c0e0686508faab2fc2e3b
ToppCell	COVID-19-T_cells-CD8+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	ITGAL SCML4 FCRL3 RESF1 CCSER2 DTHD1	5.28e-05	189	155	6	2c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCell	IPF-Lymphoid-NK\|IPF / Disease state, Lineage and Cell class	ITGAL SCML4 PTPN4 FCRL3 GZMB DTHD1	5.28e-05	189	155	6	d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	APOBEC3H ITGAL SCML4 FCRL3 GZMB IL23R	5.43e-05	190	155	6	5c6801046ab88aad76697984342319872a8f9e38
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADH1A SORT1 FBLN1 KCNA2 EFEMP1 CCN1	5.43e-05	190	155	6	00fd993675faf53adf985b9316a18c8a33242029
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGAL RBM39 SCML4 PTPN4 FCRL3 RESF1	5.43e-05	190	155	6	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN3 ADH1A IGSF10 FBLN1 EFEMP1 CCN1	5.43e-05	190	155	6	97772e69e6f51ebffbb5433ca7b40f1048723220
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BMP1 EFEMP1 PLXNA4 OSMR CDC6 ZNF471	5.43e-05	190	155	6	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	droplet-Lung-nan-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN3 ADH1A IGSF10 FBLN1 EFEMP1 CCN1	5.43e-05	190	155	6	72c2b824acdc43139e6635785df3ed3feb58ec46
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADH1A SORT1 FBLN1 KCNA2 EFEMP1 CCN1	5.43e-05	190	155	6	8cda09d761c6b504a744959d587c183f94f1beeb
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HGF TNC IGSF10 FBLN1 PLXNA4 OSMR	5.59e-05	191	155	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAT2A ADH1A SORT1 FBLN1 EFEMP1 CCN1	5.59e-05	191	155	6	80484d39f34703a33b9bac09826b7a526e883cab
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAT2A ADH1A SORT1 FBLN1 EFEMP1 CCN1	5.59e-05	191	155	6	5c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMEM67 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	5.59e-05	191	155	6	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMEM67 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	5.59e-05	191	155	6	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	ITGAL SCML4 PTPN4 FCRL3 GZMB DTHD1	5.59e-05	191	155	6	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMEM67 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	5.59e-05	191	155	6	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H PTPN4 HEG1 FCRL3 GZMB IL23R	5.76e-05	192	155	6	63e815664b228575886396387d2738cd73855759
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	APOBEC3H PTPN4 HEG1 FCRL3 GZMB IL23R	5.76e-05	192	155	6	095151a4f878944835945f698aa0e3b540ffc8c3
ToppCell	18-Distal-Immune-Hematopoietic,_Natural_Killer_Cell\|Distal / Age, Tissue, Lineage and Cell class	APOBEC3H KLHDC7B ITGAL SCML4 FCRL3 GZMB	5.76e-05	192	155	6	dd47d47d0a7219771b275c4cf5f2b768424216c8
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	TMEM67 IQCH CCDC148 CFAP52 DTHD1 MAP3K19	5.76e-05	192	155	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HGF TNC KIF26B IGSF10 FBLN1 PLXNA4	5.76e-05	192	155	6	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CRYBG3 ZFP69B KDM1B CPLANE1 VPS13B ZMYM4	5.93e-05	193	155	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HGF TNC IGSF10 FBLN1 PLXNA4 DLG2	5.93e-05	193	155	6	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	ITGAL RBM39 PTPN4 FCRL3 GZMB DTHD1	5.93e-05	193	155	6	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H ITGAL SCML4 PTPN4 GZMB CCSER2	5.93e-05	193	155	6	00349d176fb6a46cbcc99c41d975651b6e9aaad4
ToppCell	COVID-CD8-CD8_1\|COVID / Condition, Cell_class and T cell subcluster	ITGAL PTPN4 FCRL3 RESF1 GZMB DTHD1	5.93e-05	193	155	6	221690901cb214c8ee186ff527c80dcc52d1fb1c
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SCML4 PTPN4 FCRL3 GZMB DTHD1 IL23R	6.10e-05	194	155	6	5afe7f48d3383f3dac18765f97999c8b6936dc1b
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SCML4 PTPN4 FCRL3 GZMB DTHD1 IL23R	6.10e-05	194	155	6	ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	ITGAL RBM39 PTPN4 FCRL3 GZMB DTHD1	6.10e-05	194	155	6	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	COVID-19-lung-NK_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGAL SCML4 FCRL3 NBEAL2 GZMB DTHD1	6.10e-05	194	155	6	4c92f18e0a34fb50630d4b260eaf179202508b6d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HGF TNC IGSF10 FBLN1 PLXNA4 DLG2	6.10e-05	194	155	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	ITGAL RBM39 PTPN4 FCRL3 GZMB DTHD1	6.10e-05	194	155	6	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H ITGAL SCML4 PTPN4 GZMB DTHD1	6.10e-05	194	155	6	0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f
ToppCell	Monocytes-Inflammatory_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	DMXL2 DUSP5 ITGAL HEG1 NBEAL2 TSPAN14	6.10e-05	194	155	6	28d19105123b015f8aa25ea8e6c078f630d4ba80
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	ITGAL IVNS1ABP PTPN4 HEG1 GZMB DTHD1	6.10e-05	194	155	6	335c6c2f3f319d4f19eace62f8826a0f40c130f6
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H PTPN4 GZMB CCSER2 VPS13A FAM118A	6.27e-05	195	155	6	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H ITGAL SCML4 PTPN4 GZMB CCSER2	6.27e-05	195	155	6	31b011f3d54e6729802aad1f771cef77744e3ff2
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H ITGAL PTPN4 FCRL3 CCSER2 DTHD1	6.27e-05	195	155	6	42382653e977714bff453bece26a6cd66ea2cc1f
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DUSP5 SCML4 PTPN4 FCRL3 CCSER2 DTHD1	6.27e-05	195	155	6	0a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCell	T_cells-GZMK+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	APOBEC3H ITGAL PTPN4 HEG1 IGHG1 DTHD1	6.27e-05	195	155	6	003ea7ddec6c1c98d2f6470bb51ebd97450eb936
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 TMEM67 CFAP52 CPLANE1 DTHD1 MAP3K19	6.27e-05	195	155	6	79dc031258579ea328181dda33710dd897f1064a
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADH1A IGSF10 BMP1 FBLN1 HEG1 EFEMP1	6.45e-05	196	155	6	d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9
ToppCell	T_cells-GZMK+_T_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	APOBEC3H ITGAL SCML4 PTPN4 GZMB DTHD1	6.45e-05	196	155	6	fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNC IGSF10 EFEMP1 CCN1 OSMR PLXNA1	6.45e-05	196	155	6	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAT2A IVNS1ABP EIF4A1 OSMR HSPA8 NOTCH2	6.45e-05	196	155	6	97ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3H ITGAL RBM39 FCRL3 GZMB DTHD1	6.45e-05	196	155	6	17f17edadafdad9f24e88d708d7e1c765503131c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ITGAL PTPN4 FCRL3 RESF1 GZMB CCSER2	6.64e-05	197	155	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	TNC KIF26B FBLN1 TENM4 CCN1 DLG2	6.64e-05	197	155	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TNC BMP1 EFEMP1 TENM4 CCN1 OSMR	6.64e-05	197	155	6	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 TMEM67 IQCH SANBR CPLANE1 DTHD1	6.64e-05	197	155	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SCML4 PTPN4 FCRL3 RESF1 GZMB DTHD1	6.64e-05	197	155	6	cd39574b5a81a361a7940c4eb26e82652addc9e9
ToppCell	COVID-CD8\|COVID / Condition, Cell_class and T cell subcluster	ITGAL PTPN4 FCRL3 RESF1 GZMB DTHD1	6.64e-05	197	155	6	4c61ea7eba706bdc7345745941ae8b9f6a21e844
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SCML4 PTPN4 FCRL3 RESF1 GZMB DTHD1	6.64e-05	197	155	6	4946a9495ee8824540c4b45bd2a1a75696b71534
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.42e-23	46	155	15	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L8 USP17L13	1.42e-20	69	155	15	DOID:1682 (implicated_via_orthology)
Disease	brain infarction (implicated_via_orthology)	HGF HIF1A HNMT	2.27e-05	11	155	3	DOID:3454 (implicated_via_orthology)
Disease	X-25790 measurement	FAM118A MAP3K19	2.74e-05	2	155	2	EFO_0800933
Disease	Cohen syndrome (implicated_via_orthology)	VPS13A VPS13B	8.20e-05	3	155	2	DOID:0111590 (implicated_via_orthology)
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	1.63e-04	4	155	2	EFO_0020830
Disease	Cerebral Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0750935
Disease	Intracranial Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0750936
Disease	Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0004114
Disease	Grade I Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C1704230
Disease	Subependymal Giant Cell Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0205768
Disease	Mixed oligoastrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0547065
Disease	Pilocytic Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0334583
Disease	Juvenile Pilocytic Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0280783
Disease	Diffuse Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0280785
Disease	Childhood Cerebral Astrocytoma	HGF HIF1A NOTCH2	3.00e-04	25	155	3	C0338070
Disease	Gemistocytic astrocytoma	HGF HIF1A NOTCH2	3.38e-04	26	155	3	C0334581
Disease	Protoplasmic astrocytoma	HGF HIF1A NOTCH2	3.38e-04	26	155	3	C0334580
Disease	Fibrillary Astrocytoma	HGF HIF1A NOTCH2	3.38e-04	26	155	3	C0334582
Disease	Anaplastic astrocytoma	HGF HIF1A NOTCH2	3.79e-04	27	155	3	C0334579
Disease	age at onset, coronary stenosis	TSPAN14 PLD1	9.63e-04	9	155	2	EFO_0004847, MONDO_0006715
Disease	Non-Small Cell Lung Carcinoma	RAF1 HIF1A CERT1 CHFR OSMR	1.43e-03	156	155	5	C0007131
Disease	Squamous cell carcinoma of esophagus	HIF1A FAT2 BUB1B NOTCH2	1.61e-03	95	155	4	C0279626
Disease	survival time, lung adenocarcinoma	NWD2 DLG2	1.75e-03	12	155	2	EFO_0000571, EFO_0000714
Disease	disorder of pharynx	ITGAL NFKB1 IL23R	1.83e-03	46	155	3	MONDO_0020592
Disease	cholangiocarcinoma (biomarker_via_orthology)	HGF TNC	2.06e-03	13	155	2	DOID:4947 (biomarker_via_orthology)
Disease	Common variable immunodeficiency	IRF2BP2 NFKB1	2.06e-03	13	155	2	cv:C0009447
Disease	esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement	DPYSL2 CEP72	2.06e-03	13	155	2	EFO_0000280, EFO_0000478, EFO_0008343
Disease	brain ischemia (biomarker_via_orthology)	DPYSL2 HIF1A SCN5A HSPA8	2.09e-03	102	155	4	DOID:2316 (biomarker_via_orthology)
Disease	Malignant mesothelioma	RAF1 HGF EFEMP1 OSMR	2.66e-03	109	155	4	C0345967
Disease	skin aging measurement	PKD1L3 EFEMP1 KIDINS220 DTHD1 PLXNA1	2.74e-03	181	155	5	EFO_0008006
Disease	Common Variable Immunodeficiency	IRF2BP2 NFKB1	2.75e-03	15	155	2	C0009447
Disease	Endometrial Neoplasms	PLXNA3 MAP3K4 CHFR	3.55e-03	58	155	3	C0014170
Disease	Bipolar Disorder	DPYSL2 HIF1A HTR3A TENM4 SEC24C ZNF592 DLG2 PIP4K2C	3.83e-03	477	155	8	C0005586
Disease	cystathionine measurement	TEC TEC	4.42e-03	19	155	2	EFO_0010474
Disease	polycystic kidney disease (biomarker_via_orthology)	HIF1A TNC	4.42e-03	19	155	2	DOID:0080322 (biomarker_via_orthology)
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	ITGAL NFKB1 TSPAN14 OSMR FAM118A IL23R	4.79e-03	295	155	6	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	Familial aplasia of the vermis	TMEM67 CPLANE1	4.90e-03	20	155	2	cv:C0431399

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEGQKILANCSSPYQ	BUB1B	936	O60566
GVCSKQTLVVPLHYN	EGFL8	36	Q99944
SEQQCTYLKNVINPI	CCDC148	116	Q8NFR7
GNVNIVGISYQPRKC	CRYBG3	686	Q68DQ2
ENIIYISPCKQVSQI	AZIN1	106	O14977
YCLKNDVSNPQGTLQ	ADH1A	111	P07327
YIPKNGQINFSCINA	GOT1L1	371	Q8NHS2
YNPLQGQKCIVQTTS	CCN1	221	O00622
PLVCNKVAQGIVSYG	GZMB	206	P10144
RKALLCYQLTPQNGS	APOBEC3H	26	Q6NTF7
QNYKPLQVVTACSLD	HTR3A	146	P46098
TVYKACNLNLIGRPS	CRBN	361	Q96SW2
QGIVEAYRSCLPQIK	CPNE3	376	O75131
LSPQLVQYQCGDSGK	CEP72	236	Q9P209
STYISILNQKILGCQ	DMXL2	1766	Q8TDJ6
EKVCETVYQGSNLNP	DHX32	286	Q7L7V1
CGSEKPEVITSQYNN	BMP1	666	P13497
QIQACKVIVSLQYPQ	ARMC12	306	Q5T9G4
QQIYVNNALSKCTLP	NWD2	596	Q9ULI1
SCISPTIVQQFGYQR	RAF1	26	P04049
IRVGTNYQAVIPECK	RCOR2	46	Q8IZ40
QGNVYVKCPSIAAAI	RBM39	471	Q14498
NSVPFIRNKGTNIYC	OSMR	201	Q99650
PQVLTYLCLQIGKAC	IQCH	796	Q86VS3
SSSIINQYIACQGPL	PTPN4	716	P29074
YCCLVPGSIQTLKQI	INTS15	156	Q96N11
TSPQVNYPKTLQCAN	KLK13	166	Q9UKR3
PSVQKVCGRYLQQQL	KLHL30	116	Q0D2K2
SNSIELLYFIQQKCP	RADIL	511	Q96JH8
DNILCKITYVANVNP	CERT1	571	Q9Y5P4
PCQLSKGQSYSVNVT	NPC2	46	P61916
CVLPYTGKNCQTVLA	NOTCH2	821	Q04721
QAQYLQVTSCPKIPS	KCNA2	426	P16389
PQYCTTIKKANINGR	KIDINS220	1231	Q9ULH0
TCAAQLVSYPGKNKI	NCBP1	331	Q09161
CQYLNKNALTTLAGP	NELFA	141	Q9H3P2
VCLPSNGKLYTKVIN	IVNS1ABP	186	Q9Y6Y0
NSYLICQGPLSKAGQ	LRIT2	226	A6NDA9
YIRCIKPNSQGQAQT	MYO19	616	Q96H55
VQKNDILYKACQVPG	NLRP10	341	Q86W26
TIANQTNCPLYITKV	DPYSL2	241	Q16555
QHPGVLYVQKQCSNL	JMJD7	121	P0C870
QPQCIVCVNYVVSGI	HIF1A	331	Q16665
YKTCNVLVALEQQSP	MAT2A	101	P31153
SQRCKVYTQKGVLPS	KIF26B	1086	Q2KJY2
YPLGCTVLIQAINTK	CFAP52	41	Q8N1V2
KYVQCGVQPQQSSVT	TMEM63C	361	Q9P1W3
LSKVQAQYPGVCINN	HNMT	71	P50135
SAIQQRAILPCIKGY	EIF4A1	56	P60842
QQIDYKTLTLNCVNP	PLXNA1	1496	Q9UIW2
QPQSGQKNYECVVRV	PLXNA3	711	P51805
VGNQIQCYSPAAKEV	PLXNA4	606	Q9HCM2
DNSPQCSQLLYTGKV	FAT2	3006	Q9NYQ8
VGPTYSTAVLNCLKN	PDE1B	146	Q01064
CKQVLNVSQLVYGPE	HGF	561	P14210
NCGNPYQLITVVIAA	HEG1	1241	Q9ULI3
KRTLPCQAYVNQGEN	PTOV1	116	Q86YD1
INTEGSYTCQKNVPN	FBLN1	326	P23142
LFISQLSYCGPNIIN	OR6P1	161	Q8NGX9
KYQLCAQGVEEPNNT	CCSER2	71	Q9H7U1
LYNKVRTGQVPNCAV	FZD5	206	Q13467
PGYVQDLATQICKQQ	FAM118A	296	Q9NWS6
ATCLNNIPGLGYVLK	ADAM30	386	Q9UKF2
KKQTCPLQTGDVIYL	CHFR	91	Q96EP1
VIQNPQTSDSGIYKC	IGSF10	2591	Q6WRI0
EIQLTPQIAKTYRCG	KDM1B	156	Q8NB78
QGQRTKITIGVYDPC	ATG7	221	O95352
KNVPILYTASQACLQ	CTNNA1	216	P35221
SAGLAPQTKQVCVEY	CPLANE1	3096	Q9H799
NVPLKPQTSGYTCNI	CENPC	651	Q03188
GIPSQQVGSQCSYLV	CPHXL2	176	A0A1W2PPK0
IQGVVEAYQSCLPKL	CPNE4	391	Q96A23
PCGLNVQQIYSFTRK	FOXR1	191	Q6PIV2
PNIKYVFQVRCQETG	IL23R	286	Q5VWK5
CYQQAKLVLNTAVPD	CDC6	156	Q99741
VKVCDINLQSSYLNP	DTHD1	256	Q6ZMT9
KIQITEPGNYQCKTR	FCRL3	71	Q96P31
GAQQEASVVQYPDCK	HOXC8	101	P31273
TYNVNGQSPKECLRL	INPP5B	351	P32019
TLGNTIYCLNPQVTA	KLHDC7B	536	Q96G42
IYNQCKLVIEEQSGP	DLG2	846	Q15700
LGTQTYICNVNHKPS	IGHG1	76	P01857
IPNLQLYDVKTGTCL	EIF2A	106	Q9BY44
VKTILRGSCYNVQEP	C4orf36	11	Q96KX1
VYLNCVLKSDVLQPG	SEC24C	906	P53992
PNSIKILGTAISNYC	SACS	346	Q9NZJ4
ALISQCGKPVVNVSY	DUSP5	156	Q16690
QSIKQQGASGEVYCP	IRF2BP2	536	Q7Z5L9
YCGLTSQGQLIAVKQ	MAP3K19	1076	Q56UN5
IPSQQVGSQCSYLEK	CPHXL	181	A0A1W2PPM1
NQDLCQQEAVKGYPT	PDIA5	461	Q14554
QYIVKCHGNTLLPQF	PIP4K2C	171	Q8TBX8
KVCNPIITKLYQSAG	HSPA8	601	P11142
LRNKVTPNGYTLDQC	CKMT2	76	P17540
GTTYQQNCEIPISKI	TMEM67	371	Q5HYA8
QTGSKAISYPCCLIQ	OR1M1	86	Q8NGA1
TCNQGTQKSLVYGLV	MUC17	4381	Q685J3
NIIGQVCDTPKSYDN	MAP3K4	1316	Q9Y6R4
GGYLCLPKTAQIIVN	EFEMP1	66	Q12805
YQCVVLLQGKNPDIT	RARS1	291	P54136
CQNGRDYVVTKQPSI	SORT1	651	Q99523
QLSVILGYANSCANP	SSTR1	306	P30872
LACTDQQYLVPKDGQ	POLR1A	611	O95602
GQIQYCSLEEKIQSP	SFXN4	311	Q6P4A7
THPKLVQLYGVCTQQ	TEC	421	P42680
VQLYGVCTQQKPIYI	TEC	426	P42680
NIQTYLSGCPIKAQV	PLD1	71	Q13393
YKLTIGCQRVNSPIT	RGP1	136	Q92546
VYEGVPQCQCNSIKN	RESF1	1181	Q9HCM1
EGTVSPQLCQGLYKL	NBEAL2	1216	Q6ZNJ1
LTNFKGCYLTNQLPI	SLC66A1L	56	A1A4F0
GCYLTNQLPIQIFTA	SLC66A1L	61	A1A4F0
LNILPNTQKVTCFYQ	TENT5D	336	Q8NEK8
CGVQLIFQIPRTKTY	PKD1L3	1361	Q7Z443
LPLNYTIVNNKSQCE	SCN5A	1371	Q14524
PFQAVTAQLAGVKCN	TDRD7	1016	Q8NHU6
TICFQIKSLIPQFQG	ITGAL	651	P20701
NTVGTGIYPCCNQKV	SANBR	431	Q6NSI8
ISLPTQNCAYKQNIT	STXBP5	926	Q5T5C0
LKQKQISYSPGVCSI	CDC42BPA	666	Q5VT25
QFVNYPTQVLGKSCK	SLC35B1	106	P78383
QGEIQKICQTYGLRP	ACTN3	586	Q08043
ENAKPNYGCQVTIQS	ASCC3	316	Q8N3C0
PLQDYGISVAKVNCV	TXNDC16	71	Q9P2K2
QCIYPLGSKSLNNLI	USPL1	76	Q5W0Q7
TVLQPCDLFYQTTQK	VPS13A	1621	Q96RL7
TYLQAKQAAGIINVP	SPEN	3601	Q96T58
QLFSISPCQISQIYK	TFCP2	446	Q12800
YQNVSKTQVGVFKCP	ZNF592	881	Q92610
VTGNKIAKNVQYPEC	USP17L18	286	D6R9N7
NHVYNIKLPVGSQCS	TNC	51	P24821
KLIGTNCIIYPVNSK	UBE2O	176	Q9C0C9
VTGNKIAKNVQYPEC	USP17L5	286	A8MUK1
VTGNKIAKNVQYPEC	USP17L21	286	D6R901
VTGNKIAKNVQYPEC	USP17L13	286	C9JLJ4
QLYGSTITSCQQAPK	TENM4	2541	Q6N022
TDAGCNLNPLQYIKQ	SCFD1	481	Q8WVM8
VTGNKIAKNVQYPEC	USP17L19	286	D6RCP7
VTGNKIAKNVQYPEC	USP17L12	286	C9JPN9
NYQSLVSLGLCISKP	ZNF471	46	Q9BX82
NYGNLVSVGCQLSKP	ZFP69B	106	Q9UJL9
VTGNKIAKNVQYPEC	USP17L24	286	Q0WX57
IKCSNPQVQLFYELT	VPS13B	1216	Q7Z7G8
GYNGLNQCLPTTQSK	ZNF681	126	Q96N22
VTGNKLAKNVQYPEC	USP17L8	286	P0C7I0
AQLYKDRVCQQPGLS	TAPR1	71	Q14CZ0
PAQKVVNTQCGYDVR	TSPAN14	191	Q8NG11
VTGNKIAKNVQYPEC	USP17L6P	286	Q6QN14
TKIYHPNINSNGSIC	UBE2D4	71	Q9Y2X8
YTSGQTILQNRKPCS	TSNAXIP1	11	Q2TAA8
VTGNKIAKNVQYPEC	USP17L22	286	D6RA61
VTGNKIAKNVQYPEC	USP17L17	286	D6RBQ6
VVNQSSPKNCTVYCG	TIAL1	196	Q01085
GVDPNQYTKVILCQL	UIMC1	286	Q96RL1
PQALTVCLYINKQAN	SCML4	91	Q8N228
SYCLQTSPKLVQNNL	ZMYM4	776	Q5VZL5
VTGNKLAKNVQYPEC	USP17L2	286	Q6R6M4
VTGNKIAKNVQYPEC	USP17L20	286	D6RJB6
IISDDVCKQPQVYGN	TMPRSS11A	331	Q6ZMR5
VTGNKIAKNVQYPEC	USP17L10	286	C9JJH3
TKIYHPNINSNGSIC	UBE2D1	71	P51668
VTGNKIAKNVQYPEC	USP17L11	286	C9JVI0
VSYVQTLCKGLSQPT	NEUROD2	186	Q15784
ICNYVGPAKVIVQLV	NFKB1	86	P19838